Reply: Promise and Limitations of Relaxin-based Therapies in Chronic Fibrotic Lung Diseases
Am J Respir Crit Care Med
.
2016 Dec 1;194(11):1435-1436.
doi: 10.1164/rccm.201607-1464LE.
Authors
Jiangning Tan
1
,
Daniel J Kass
1
Affiliation
1
1 University of Pittsburgh Pittsburgh, Pennsylvania.
PMID:
27905855
PMCID:
PMC5148147
DOI:
10.1164/rccm.201607-1464LE
No abstract available
Publication types
Comment
MeSH terms
Humans
Lung Diseases*
Relaxin*
Substances
Relaxin
Grants and funding
R01 HL126990/HL/NHLBI NIH HHS/United States